Lactase enzymes with improved properties

US11525129B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11525129-B2
Application numberUS-201816604129-A
CountryUS
Kind codeB2
Filing dateApr 11, 2018
Priority dateApr 11, 2017
Publication dateDec 13, 2022
Grant dateDec 13, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are peptides and dimeric peptides exhibiting beta-galactosidase enzyme activity, as well as methods for producing a dairy product using them, and dairy products made by such methods. In some embodiments, the peptides exhibit beta-galactosidase enzyme activity at low and/or high temperatures.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a dairy product, comprising treating a milk-based substrate comprising lactose with a peptide selected from peptides having the amino acid sequence of any one of SEQ ID NO:1, SEQ ID NO:22, or SEQ ID NO:32, and variants thereof having from 1 to 5 amino acid substitutions, additions or deletions relative thereto, wherein said treating takes place at a pH of 4 to 7 and at a temperature selected from (i) a temperature of not more than 25° C. and (ii) a temperature of between 40° C. and 100° C. wherein the peptide exhibits beta-galactosidase enzyme activity at the temperature and reduces lactose content of the substrate. 2. The method according to claim 1 , wherein said treating takes place at a temperature of not more than 25° C. 3. The method according to claim 1 , wherein said dairy product is fermented milk product and said treating is performed during or prior to fermentation. 4. The method according to claim 1 , which method does not require the addition of further enzyme after fermentation. 5. The method according to claim 1 , wherein said dairy product is a fermented milk product and said treating is performed immediately following fermentation. 6. The method according to claim 1 , wherein said dairy product is fresh milk and said treating is performed prior to, in conjunction with, or immediately following pasteurization. 7. The method according to claim 1 , wherein said dairy product is ultra-heat treated (UHT) milk and said treating is performed prior to, in conjunction with, or immediately following ultra-heat treatment. 8. The method according to claim 1 , wherein said treating takes place at a temperature of between 40° C. and 100° C. 9. The method according to claim 1 , wherein the method comprises treating said milk-based substrate with said peptide, wherein said peptide has the amino acid sequence of SEQ ID NO:1 or a variant thereof having from 1 to 5 amino acid substitutions relative thereto. 10. The method according to claim 9 , wherein said peptide has the amino acid sequence of SEQ ID NO:1. 11. The method according to claim 1 , wherein the method comprises treating said milk-based substrate with said peptide, wherein said peptide has the amino acid sequence of SEQ ID NO:22 or a variant thereof having from 1 to 5 amino acid substitutions relative thereto, wherein said peptide exhibits beta-galactosidase enzyme activity at 72° C. 12. The method according to claim 11 , wherein said peptide has the amino acid sequence of SEQ ID NO:22. 13. The method according to claim 1 , wherein the method comprises treating said milk-based substrate with said peptide, wherein said peptide has the amino acid sequence of SEQ ID NO:32 or a variant thereof having from 1 to 5 amino acid substitutions relative thereto. 14. The method according to claim 9 , wherein said peptide has the amino acid sequence of SEQ ID NO:32.

Assignees

Inventors

Classifications

  • Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase · CPC title

  • C07K14/195Primary

    from bacteria · CPC title

  • C12N9/2471Primary

    Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase · CPC title

  • Enzymes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11525129B2 cover?
Disclosed are peptides and dimeric peptides exhibiting beta-galactosidase enzyme activity, as well as methods for producing a dairy product using them, and dairy products made by such methods. In some embodiments, the peptides exhibit beta-galactosidase enzyme activity at low and/or high temperatures.
Who is the assignee on this patent?
Chr Hansen As
What technology area does this patent fall under?
Primary CPC classification C07K14/195. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).